Get started
Author

Trudi McDevitt

Observed names: McDevitt, Trudi, T M McDevitt, T McDevitt, T. McDevitt, T. Trudi McDevitt, TRUDI McDEVITT
Observed institutions: University College Dublin, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, University of St Andrews, Aston University, University of Aberdeen, Children's Health Ireland at Crumlin, Molecular Medicine Ireland, Our Lady's Hospital
ORCID: 0009-0008-2425-5194
Observed ORCID: 0009-0008-2425-5194
OpenAlex ID: A5007125743
Characterization of a cancer cachectic factor
1996 · Penio Todorov, Peter Cariuk, et al. · Nature · 437
Purification and characterization of a tumor lipid-mobilizing factor.
1998 · P T Todorov, T M McDevitt, et al. · PubMed · 182
Gross genomic rearrangements involving deletions in the CFTR gene: characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms
2006 · Claude Férec, Teresa Casals, et al. · European Journal of Human Genetics · 93
Induction of muscle protein degradation and weight loss by a tumor product.
1996 · P T Todorov, T M McDevitt, et al. · PubMed · 84
Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans.
1995 · T M McDevitt, P T Todorov, et al. · PubMed · 47
Detection of novel germline mutations for breast cancer in non‐ BRCA 1/2 families
2015 · Fatima Aloraifi, Trudi McDevitt, et al. · FEBS Journal · 46
Predictive testing for BRCA1 and 2 mutations: a male contribution
2003 · P.A. Daly, C. Nolan, et al. · Annals of Oncology · 39
PDF
Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci
2010 · Sylvia Quemener, Jian-Min Chen, et al. · Human Mutation · 34
PDF
Protein-truncating variants in moderate-risk breast cancer susceptibility genes: A meta-analysis of high-risk case-control screening studies
2015 · Fatima Aloraifi, Damian McCartan, et al. · Cancer Genetics · 29
EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer
2024 · Trudi McDevitt, Miranda Durkie, et al. · European Journal of Human Genetics · 23
PDF
Comparison of the CFTR mutation spectrum in three cohorts of patients of Celtic origin from Brittany (France) and Ireland
2003 · Virginie Scotet, David E. Barton, et al. · Human Mutation · 21
PDF
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)
2024 · Alice Garrett, Sophie Allen, et al. · Genetics in Medicine · 17
PDF
Phenotypic analysis of familial breast cancer: Comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer
2015 · F. Aloraifi, M. Alshehhi, et al. · European Journal of Surgical Oncology · 17
PDF
THE EFFECTS OF MONENSIN ON THE ABUNDANCE OF mRNA(α) AND OF SODIUM PUMPS IN HUMAN CULTURED CELLS
1989 · G. Cramb, C. P. Cutler, et al. · Quarterly Journal of Experimental Physiology · 14
Cascade screening in BRCA1/2 mutation carriers.
2008 · N Cody, A Green, et al. · PubMed · 13
Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants
2021 · Lucy Loong, Cankut Cubuk, et al. · Genetics in Medicine · 12
PDF
Validating data from multiplex assays of variant effect: A CanVIG-UK national survey of NHS clinical scientists
2025 · Sophie Allen, Alice Garrett, et al. · The American Journal of Human Genetics · 9
The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification
2024 · Charlie F. Rowlands, Alice Garrett, et al. · Journal of Medical Genetics · 8
Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series
2017 · Terri P. McVeigh, Nuala Cody, et al. · Cancer Genetics · 8
Availability of benign missense variant “truthsets” for validation of functional assays: Current status and a systematic approach
2025 · Charlie F. Rowlands, Sophie Allen, et al. · The American Journal of Human Genetics · 6
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey
2023 · Sophie Allen, Lucy Loong, et al. · Journal of Medical Genetics · 6
PDF
Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome
2012 · Michael P. Farrell, David J. Hughes, et al. · Familial Cancer · 4
Quantifying evidence for phenotypic specificity (PP4) for syndromic phenotypes: Large-scale integration of rare germline FH variants from diagnostic laboratory testing for HLRCC and renal cancer
2025 · Sophie Allen, Charlie F. Rowlands, et al. · Genetics in Medicine · 3
Familial breast cancer genetic testing in the West of Ireland
2013 · T. P. McVeigh, R. Irwin, et al. · Irish Journal of Medical Science (1971 -) · 3
Cancer Variant Interpretation Group UK (CanVIG-UK): updates on an exemplar national subspecialty multidisciplinary network
2026 · Alice Garrett, Sophie Allen, et al. · Journal of Medical Genetics · 1
Works count: 61
Citation count: 1,162
H-index: 14
I10-index: 16
Year
Topic
Type